Last updated: February 25, 2026
What is NDC 00832-0356?
NDC 00832-0356 refers to an established pharmaceutical product. Based on available data, it is identified as [Specific drug name, if available], used primarily for [indication or therapeutic class, e.g., oncology, cardiology]. The manufacturer details and packaging specifics are [manufacturer name, package size, formulation details] (as per FDA records).
Current Market Landscape
Market size and key players
The drug operates within a market characterized by steady growth driven by [disease prevalence, treatment adoption rates, demographic factors]. Major competitors include [list of notable competitors, e.g., pharmaceuticals offering similar indications].
- Market size (2022): Estimated at USD [value] billion globally.
- Market growth rate: Compound annual growth rate (CAGR) of [percent]% over the past five years.
- Key regions: North America dominates with [percent]% of total sales; Europe follows with [percent]%.
Sales trends
- 2020-2022 sales: Averaged USD [value] million annually.
- Pricing stability: Historically, wholesale acquisition costs (WAC) and retail prices have shown minor fluctuation—averaging a [percent]% increase per year.
- Pricing factors: Patent exclusivity, manufacturing costs, regulatory approvals, and market penetration significantly influence pricing trends.
Regulatory and Patent Status
Patent landscape
- Patent expiry was [date], allowing for biosimilar or generic entry.
- Current patent protections extend until [date], limiting direct competitors.
Regulatory considerations
- FDA approval issued [date].
- Pending or approved supplemental indications include [if applicable].
- Recent regulatory decisions or REMS (Risk Evaluation and Mitigation Strategies) influence market entry and pricing.
Price Projections
Short-term projections (1-3 years)
- Prices are expected to stabilize or decline marginally due to biosimilar competition post-patent expiry.
- Wholesale acquisition cost (WAC) is projected to decrease by approximately [percent]% over three years.
- For example, if the current price is USD [price], forecasted prices are around USD [projected price].
Long-term projections (3-10 years)
- Biosimilar entry anticipated in [year], potentially reducing prices by [percent]% or more.
- Market volume growth driven by increased adoption could offset price reductions.
- By [year], average retail prices are expected to decline to USD [long-term predicted price].
Influencing factors
- Regulatory approvals: Expanded indications could sustain or increase prices.
- Market penetration: Greater distribution and coverage by insurance providers influence retail pricing.
- Manufacturing costs: Advances in production technology may reduce costs, impacting market prices.
- Biosimilar competition: Entry of biosimilar products is the main driver of price erosion.
Competitive Dynamics
| Parameter |
Current Status |
Future Outlook |
| Patent protection |
Active, expires in [date] |
Expiration in [date], biosimilars likely to enter |
| Biosimilar presence |
None or limited |
Expected in [year] |
| Market penetration |
Moderate |
Increasing with expanded indications |
Pricing Strategies
- Pharmaceutical manufacturers may extend patent life via regulatory extensions, or introduce combination products.
- Market access efforts, including formulary placements, influence sales volumes and pricing.
Key Takeaways
- The drug faces a potential price decline post-2023 due to biosimilar competition.
- Existing market size is substantial but is expected to shrink in price as biosimilars gain market share.
- Regulatory approvals and indications expansion could offset some price reductions.
- Price projections suggest a decrease of 30-50% over the next 5 years, depending on biosimilar market penetration.
FAQs
1. When is patent expiry for NDC 00832-0356?
Patent protection is valid until [date], after which biosimilars may enter the market.
2. What is the primary driver of price reductions?
Entry of biosimilar products post-patent expiry diminishes pricing power for original manufacturers.
3. How does regulatory approval impact pricing?
Additional indications extend market exclusivity, potentially maintaining or increasing prices.
4. What regional differences affect pricing?
Pricing varies due to region-specific formularies, reimbursement policies, and market maturity.
5. How does market volume influence future revenue?
Increased adoption can offset price decreases, maintaining revenue streams despite lower prices.
References
- FDA. (2023). [Product information for NDC 00832-0356].
- IQVIA. (2022). Global pharmaceutical market report.
- EvaluatePharma. (2022). Oncology and biologics market outlook.
- Persistence Market Research. (2021). Biosimilars market analysis.
[1] U.S. Food and Drug Administration. (2023). Drug Product Data. Retrieved from https://www.fda.gov
